• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性骨化性纤维发育不良的非典型表现及多学科护理的必要性:一例报告

An Atypical Presentation of Fibrodysplasia Ossificans Progressiva and the Imperative for Multidisciplinary Care: A Case Report.

作者信息

Saeed Shahzeb, Naveed Husnain, Maktabijahromi Niloufar, Mohammed Norhan, Rehman Abdur

机构信息

Internal Medicine, Army Medical College, Rawalpindi, PAK.

Internal Medicine, Shifa Tameer-E-Millat University Shifa College of Medicine, Islamabad, PAK.

出版信息

Cureus. 2023 Aug 10;15(8):e43309. doi: 10.7759/cureus.43309. eCollection 2023 Aug.

DOI:10.7759/cureus.43309
PMID:37700978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10493469/
Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by the gradual heterotopic ossification of soft tissues, leading to abnormal bone growth within muscles, tendons, and ligaments, due to a mutation in the ACVR1 gene. This specific case report highlights an unusual occurrence of FOP, emphasizing the diagnostic challenges and the importance of quick identification and appropriate intervention to mitigate its debilitating effects. The report also underscores the need for comprehensive genetic counseling and a multidisciplinary treatment approach, involving experts, such as orthopedic specialists, geneticists, and physical therapists, to improve the prognosis and overall well-being of those affected by FOP.

摘要

进行性骨化性纤维发育不良(FOP)是一种罕见的遗传性疾病,其特征是软组织逐渐发生异位骨化,由于ACVR1基因突变,导致肌肉、肌腱和韧带内出现异常骨生长。本病例报告突出了FOP的罕见情况,强调了诊断挑战以及快速识别和适当干预以减轻其衰弱影响的重要性。该报告还强调了全面遗传咨询和多学科治疗方法的必要性,涉及骨科专家、遗传学家和物理治疗师等专家,以改善FOP患者的预后和整体健康状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d2/10493469/5ba74a63aa98/cureus-0015-00000043309-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d2/10493469/4db986e54bd6/cureus-0015-00000043309-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d2/10493469/5ba74a63aa98/cureus-0015-00000043309-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d2/10493469/4db986e54bd6/cureus-0015-00000043309-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d2/10493469/5ba74a63aa98/cureus-0015-00000043309-i02.jpg

相似文献

1
An Atypical Presentation of Fibrodysplasia Ossificans Progressiva and the Imperative for Multidisciplinary Care: A Case Report.进行性骨化性纤维发育不良的非典型表现及多学科护理的必要性:一例报告
Cureus. 2023 Aug 10;15(8):e43309. doi: 10.7759/cureus.43309. eCollection 2023 Aug.
2
BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).骨纤维发育不良性骨化症(FOP)中的 BMP 信号和骨骼发育。
Dev Dyn. 2022 Jan;251(1):164-177. doi: 10.1002/dvdy.387. Epub 2021 Jun 26.
3
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.典型和非典型进行性骨化性纤维发育不良(FOP)表型是由骨形态发生蛋白(BMP)I型受体ACVR1中的突变引起的。
Hum Mutat. 2009 Mar;30(3):379-90. doi: 10.1002/humu.20868.
4
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.在进行性骨化性纤维发育不良中发现的ACVR1 R206H突变通过BMP介导的SMAD1/5/8信号通路增加人诱导多能干细胞衍生的内皮细胞形成和胶原蛋白生成。
Stem Cell Res Ther. 2016 Aug 17;7(1):115. doi: 10.1186/s13287-016-0372-6.
5
Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Mouse Model of Fibrodysplasia Ossificans Progressiva.破骨细胞和巨噬细胞耗竭可损害 Acvr1 小鼠纤维性骨发育不良进展性异位骨化模型中的异位骨化。
J Bone Miner Res. 2018 Feb;33(2):269-282. doi: 10.1002/jbmr.3304. Epub 2018 Jan 3.
6
Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.进行性骨化性纤维发育不良(FOP):一种骨软骨发生障碍。
Bone. 2020 Nov;140:115539. doi: 10.1016/j.bone.2020.115539. Epub 2020 Jul 27.
7
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1.抗ACVR1抗体通过激活进行性骨化性纤维发育不良(FOP)中的FOP突变型ACVR1,加剧了异位骨化。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI153792.
8
An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.一种 mTOR 信号调节剂抑制纤维发育不良性骨化性纤维发育不良的异位骨化。
Stem Cell Reports. 2018 Nov 13;11(5):1106-1119. doi: 10.1016/j.stemcr.2018.10.007. Epub 2018 Nov 1.
9
Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.帕罗维罗汀可抑制携带人类ACVR1(R206H)突变的进行性骨化性纤维发育不良(FOP)小鼠的异位骨化,并维持肢体活动能力和生长。
J Bone Miner Res. 2016 Sep;31(9):1666-75. doi: 10.1002/jbmr.2820. Epub 2016 Mar 12.
10
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.野生型 ACVR1 在进行性骨化性纤维发育不良小鼠中的过表达可挽救围产期致死性并抑制异位骨化。
J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3.

本文引用的文献

1
The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey.纤维性骨发育不良进展性(FOP)对患者及其家庭成员的影响:一项国际疾病负担调查的结果。
Expert Rev Pharmacoecon Outcomes Res. 2022 Dec;22(8):1199-1213. doi: 10.1080/14737167.2022.2115360. Epub 2022 Sep 21.
2
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.骨化性纤维发育不良进展性:我们已经取得了哪些成就,现在又在哪里?对 2015 年洛伦茨研讨会的跟进。
Front Endocrinol (Lausanne). 2021 Nov 10;12:732728. doi: 10.3389/fendo.2021.732728. eCollection 2021.
3
Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish.
进行性骨化性纤维发育不良突变型 ACVR1 在发育中的斑马鱼中通过多种方式发出信号。
Elife. 2020 Sep 8;9:e53761. doi: 10.7554/eLife.53761.
4
Analysis of clinical manifestations and treatment in 26 children with fibrodysplasia ossificans progressiva in China.中国 26 例进行性骨化性纤维发育不良患儿的临床表现与治疗分析。
World J Pediatr. 2020 Feb;16(1):82-88. doi: 10.1007/s12519-019-00302-x. Epub 2019 Sep 16.
5
ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells.ECSIT 在 FOP 结缔组织祖细胞中连接 TLR 和 BMP 信号通路。
Bone. 2018 Apr;109:201-209. doi: 10.1016/j.bone.2017.12.024. Epub 2017 Dec 27.
6
Clinical and Genetic Analysis of Fibrodysplasia Ossificans Progressiva: A Case Report and Literature Review.进行性骨化性纤维发育不良的临床与遗传学分析:一例报告及文献复习
J Clin Diagn Res. 2015 Aug;9(8):RD01-3. doi: 10.7860/JCDR/2015/15160.6393. Epub 2015 Aug 1.
7
Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.进行性骨化性纤维发育不良:诊断、管理及治疗前景
Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2(0 2):437-48.
8
Fibrodysplasia ossificans progressiva: report of a case and review of articles.进行性骨化性纤维发育不良:1例报告并文献复习
Iran J Radiol. 2011 Sep;8(2):113-7. Epub 2011 Sep 25.
9
Fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良
Best Pract Res Clin Rheumatol. 2008 Mar;22(1):191-205. doi: 10.1016/j.berh.2007.11.007.